Avastin — Class II drug recall D-1119-2015
Terminated recall by Montana Compounding Pharmacy, reported 2015-06-17, distributed in MT, ND. Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
| Recall number | D-1119-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Montana Compounding Pharmacy, Missoula, MT, United States |
| Recall initiated | 2015-05-15 |
| Classified | 2015-06-09 |
| Reported by FDA | 2015-06-17 |
| Terminated | 2016-12-20 |
| Distributed | MT, ND |
| Quantity | 259 |
| Reason classes | sterility |
| Expiration dates | 2015-05-20, 2015-05-24, 2015-06-02, 2015-06-12 |
Product
Avastin, solution, 1.25 mg/0.05mL, Injectable, Syringe, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT
Reason for recall
Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1119-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.